What Pharmacophore modelling is designed to address
Pharmacophore modelling is not a one-score software run. It is a reviewable analysis path organised around “Which spatial features are most important for recognising and prioritising candidate molecules?”, beginning with input quality, comparators and intended use of evidence before selecting an appropriate methodological level.
The work centres on Ligand-based pharmacophores, Structure-based pharmacophores, Hypothesis validation and virtual screening and links Active and inactive molecules, Optional complex structures, Assay context and activity thresholds directly to Interpretable pharmacophore hypotheses, Feature matches and excluded volumes, Hit lists with applicability notes. Reporting separates supporting evidence, conflicting signals, parameter dependence and conditions for follow-up validation.
Which spatial features are most important for recognising and prioritising candidate molecules?
Suitable research settings
- Projects that need to answer “Which spatial features are most important for recognising and prioritising candidate molecules?”
- Studies requiring consistent comparison and quality control across Ligand-based pharmacophores and Structure-based pharmacophores
- Teams that need Interpretable pharmacophore hypotheses, Feature matches and excluded volumes, Hit lists with applicability notes with complete reproduction records
Analyses included in the service
Ligand-based pharmacophores
Apply Ligand-based pharmacophores to active and inactive molecules and produce interpretable pharmacophore hypotheses. First confirm that active and inactive molecules can support the downstream analysis.
Structure-based pharmacophores
Apply Structure-based pharmacophores to optional complex structures and produce feature matches and excluded volumes. Use consistent systems, conditions and naming across adjacent steps so comparisons remain reviewable.
Hypothesis validation and virtual screening
Apply Hypothesis validation and virtual screening to assay context and activity thresholds and produce hit lists with applicability notes. Use consistent systems, conditions and naming across adjacent steps so comparisons remain reviewable.
Select the methodological level for the question
| Method | Best suited to | Watch for |
|---|---|---|
| Ligand-based pharmacophores | Establishing the input baseline and initial search space for Pharmacophore modelling | Errors in Pharmacophore modelling input state, structure or data definition propagate through later steps |
| Structure-based pharmacophores | Comparing candidate states, features or mechanisms in Pharmacophore modelling to form priorities | Pharmacophore modelling comparisons require consistent conditions; raw scores are not experimental measurements |
| Hypothesis validation and virtual screening | Reviewing key Pharmacophore modelling results, interpreting differences and recording uncertainty | A pharmacophore reflects shared features supported by the selected data; it does not prove a unique binding mode and depends on conformer and label quality. |
From question definition to reproducible delivery
Frame the research question
Use “Which spatial features are most important for recognising and prioritising candidate molecules?” to define comparators, decision use, experimental context and the strength of evidence the computation can support.
Review and curate inputs
Review Active and inactive molecules, Optional complex structures, Assay context and activity thresholds; resolve structure, naming, unit, batch or microstate issues and record any remaining assumptions.
Design methods and controls
Combine Ligand-based pharmacophores, Structure-based pharmacophores, Hypothesis validation and virtual screening with controls, replicates, sensitivity checks or independent evidence, defining decision criteria before computation.
Compute with quality control
Run Pharmacophore modelling, including Ligand-based pharmacophores, in a reproducible environment; retain inputs, versions, parameters, logs and intermediate outputs, and flag convergence, sampling, data-quality and applicability issues.
Interpret and deliver
Organise Interpretable pharmacophore hypotheses, Feature matches and excluded volumes, Hit lists with applicability notes while separating direct observations, model inference and working hypotheses, then prioritise experiments or follow-up computation.
What is needed and what is delivered
Inputs
- Active and inactive molecules
- Optional complex structures
- Assay context and activity thresholds
Optional supporting inputs
- Known positive, negative or reference systems for basic expectation checks in Pharmacophore modelling
- Replicate experiments, external databases or literature evidence relevant to Pharmacophore modelling
- Timing, compute, software-compatibility or delivery-format constraints for Pharmacophore modelling
Deliverables
- Interpretable pharmacophore hypotheses
- Feature matches and excluded volumes
- Hit lists with applicability notes
Quality control and interpretation limits
How results are reviewed
- Pharmacophore modelling: Standardise chemical structures, target states and assay context
- Pharmacophore modelling: Review against known actives, decoys or simple baselines
- Pharmacophore modelling: Record applicability domain, score agreement and uncertainty
- Pharmacophore modelling: Check diversity, synthesizability and experimental testability
Boundaries that remain
- A pharmacophore reflects shared features supported by the selected data; it does not prove a unique binding mode and depends on conformer and label quality.
- Pharmacophore modelling results apply only to the recorded inputs, parameters, models and sampling scope. Changes to input state, comparison conditions or project objectives may require new computation.
Common ways projects begin
From one system to comparable candidates
When active and inactive molecules are available but decision criteria are inconsistent, establish baselines and controls, then use Ligand-based pharmacophores, Structure-based pharmacophores, Hypothesis validation and virtual screening to build candidate tiers and deliver interpretable pharmacophore hypotheses with a difference analysis.
Independent review of existing results
When results relevant to Pharmacophore modelling conflict, revisit active and inactive molecules and analytical assumptions around Ligand-based pharmacophores, then add replicates, sensitivity checks or alternative models to distinguish signal from method conditions.
Questions before a project begins
What is required before Pharmacophore modelling begins?
The minimum inputs are Active and inactive molecules, Optional complex structures, Assay context and activity thresholds. If information is incomplete, an input audit identifies which gaps change method selection and which can be handled as explicit assumptions.
Can the result directly prove “Which spatial features are most important for recognising and prioritising candidate molecules?”?
No single model output should be treated as experimental fact. A pharmacophore reflects shared features supported by the selected data; it does not prove a unique binding mode and depends on conformer and label quality. Quality controls determine whether results support a priority or mechanism hypothesis; key conclusions still require appropriate experiments or independent data.
Which reusable files are delivered?
Typical delivery includes Interpretable pharmacophore hypotheses, Feature matches and excluded volumes, Hit lists with applicability notes, together with input-curation records, key parameters, software and database versions, quality-control results, editable figures and limitations. Exact raw formats are confirmed in the project plan.